Ester is a multidisciplinary scientist with a background in biotechnology and bioengineering. After working in different roles across startups, pharma, and consulting, she is now the Director of Strategic Innovation at Chiesi USA, where she is scouting companies for partnerships or acquisitions that have innovative technologies to treat patients with rare diseases.

At MIT, Ester developed a pill to administer insulin orally, and was recognized as one of the 35 Innovators Under 35 by the MIT Technology Review in 2019. She serves as an advisor to various international startups. Ester speaks seven languages and is passionate about advocating on career development for women in science.